"Medical and translational research will become a lot more data-driven, and we are really set up for this new dimension." 💬 🗣️ CEO Ulf Nehrbass previews LIH's Annual Report in Part 3 of 3 as we revisit our achievements across 2023. Read in full: lih.lu/en/annual-repo…

Take a look below at this fantastic thread 🧵 from Brenner Lab, Group Leader in our Department of Infection & Immunity.

🗓️ #Luxembourg National #PhD Welcome Day is back - Save the date & Register right now❗️ On September 13, all the new #doctoralux candidates enrolled in one the #ResearchLuxembourg institutions are invited to join the annual event 🚨Registration page➡️liser.lu/?type=module&i…

Gut-Brain axis: Gut microbial factors, including microbial networks and bidirectional host-microbe interactions, predict severity of multiple sclerosis. Check out our new paper in Nature Microbiology nature.com/articles/s4156….

Launched in 2023, Colive Cancer is a project by the #Luxembourg Institute of Health aimed at enhancing #cancer care in the country through patient feedback. 💙 Learn more in our Annual Report and hear from study leader Guy Fagherazzi: lih.lu/en/annual-repo… 🔗colivecancer.lu

📰 Un article du Luxembourg Times montrant l’impact de la recherche participative pour améliorer la prise en charge des patients et la recherche sur le #CovidLong ! #ApresJ20 #LongCovid 1/5 luxtimes.lu/yourluxembourg…

We made it on the cover of Cell Metabolism! Incredible artwork & research by Lynn Bonetti LIH_Luxembourg, our lab & collaborators. ROS, glutathione, mitochondria, ETC, Th17 cells, infections & gut health! Check it out Luxembourg National Research Fund (FNR) uni.lu science.lu Immunometabolism Network European ImmunoMetabolism Network

#HIRING 🚨 We spoke to Brice Appenzeller, coordinator of Xpose to find out what you can expect from the Doctoral Training Program. We are currently recruiting for 12 PhD positions! 🌐 More Info: xpose.lih.lu 📩 Apply Here: lih.lu/en/job/?value=… #PhD #Luxembourg

Discover the results of a 🆕 study in #OpenAccess that was led by LISER's research programme 'Health & #HealthSystems'. ✍🏻 Co-authored by V. Moran, M. Bia, P. Thill, Marc Suhrcke , Ellen Nolte, Eric Burlot & Guy Fagherazzi 🔗 LIH_Luxembourg press release: lih.lu/en/article/lux…

A study led by LIH and LISER has highlighted the effectiveness of Luxembourg’s Referring Doctor (RD) programme in improving care for Type 2 #diabetes. The success of this initiative suggests a potential for treating other chronic conditions. lih.lu/en/article/lux…

LIH’s Experimental & Molecular Immunology group led by Brenner Lab has found a link between antioxidants in immune cells and #guthealth, which could transform treatments for Crohn’s & ulcerative colitis. Featured on the cover of Cell Metabolism! MORE: lih.lu/en/article/get…

Successful PhD Defence 🏆 Congratulations to LIH researcher Christie from our Immuno-Pharmacology and Interactomics group who defended her thesis last month at uni.lu.

In 2023, LIH's Human Biomonitoring Research Unit, with Anses and Ineris, revealed how #hairanalysis tracks chemicals like bisphenols and pesticides that are quickly eliminated from the body. Learn more in our Annual Report 👇 🔗lih.lu/en/annual-repo…

Hello from Gdańsk, Poland where we attend #INECS2024 #CA21152 conference ⁦inecancersurvivorship⁩ ! We are excited to learn more about digital solutions in #cancer #survivorship

“Voice features hold great potential to assess smoking status.” Dr Guy Fagherazzi and our LIH DDP Lab have developed a rapid and accurate #AI-powered #vocalbiomarker to detect if someone smokes, just by listening to their voice! 🌍🎙️ Learn more: lih.lu/en/article/lih…